Bioprosthetic heart valves are implantable devices made from animal tissues and used by patients suffering from valvular heart disease. These valves are highly preferred due to its strong and flexible properties. Increasing geriatric population and rising valvular diseases associated with them are considered as major factors driving the market growth. According to several studies, more than 80,000 aortic valve replacement procedures are performed every year in the US which in turn increase the demand for heart valve implantation. Furthermore, increasing awareness and government initiatives for implantation procedures is expected to motivate the market growth.